CGTLive®’s Weekly Rewind – May 17, 2024
Review top news and interview highlights from the week ending May 17, 2024.
CGTLive®’s Weekly Rewind – May 10, 2024
Review top news and interview highlights from the week ending May 10, 2024.
CGTLive®’s Weekly Rewind – May 3, 2024
Review top news and interview highlights from the week ending May 3, 2024.
FDA Activity Recap: April 2024 Features New Product Approval, 2 Expanded Indication Approvals, and More
Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive® team.
CGTLive®’s Weekly Rewind – April 26, 2024
Review top news and interview highlights from the week ending April 26, 2024.
CGTLive®’s Weekly Rewind – April 19, 2024
Review top news and interview highlights from the week ending April 19, 2024.
CGTLive®’s Weekly Rewind – April 12, 2024
Review top news and interview highlights from the week ending April 12, 2024.
CGTLive®’s Weekly Rewind – April 5, 2024
Review top news and interview highlights from the week ending April 5, 2024.
FDA Activity Recap: March 2024 Features 2 Major Approvals, ODAC Meeting, and More
CGTLive®’s Weekly Rewind – March 29, 2024
Review top news and interview highlights from the week ending March 29, 2024.
CGTLive®’s Weekly Rewind – March 22, 2024
Review top news and interview highlights from the week ending March 22, 2024.
CGTLive®’s Weekly Rewind – March 15, 2024
Review top news and interview highlights from the week ending March 15, 2024.
CGTLive®’s Weekly Rewind – March 8, 2024
Welcome to CGTLive®’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.
FDA Activity Recap: February 2024 Features Major Approval, Priority Review for a BLA Efficacy Supplement, and PDUFA Date Change
CGTLive®’s Weekly Rewind – March 1, 2024
CGTLive’s Weekly Rewind – February 23, 2024
Review top news and interview highlights from the week ending February 23, 2024.
CGTLive’s Weekly Rewind – February 16, 2024
Review top news and interview highlights from the week ending February 16, 2024.
CGTLive’s Weekly Rewind – February 9, 2024
Review top news and interview highlights from the week ending February 9, 2024.
FDA Activity Recap: January 2024 Features Major Approval, New Black Box Warnings, and Updated Guidance Documents
Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive™ team.
Top News in Oncology Cell Therapy for World Cancer Day 2024
For World Cancer Day, held annually on February 4, take a look at the stories that have stood out in oncology cell therapy so far this year.
CGTLive’s Weekly Rewind – February 2, 2024
Review top news and interview highlights from the week ending February 2, 2024.
CGTLive’s Weekly Rewind – January 26, 2024
Review top news and interview highlights from the week ending January 26, 2024.
CGTLive’s Weekly Rewind – January 19, 2024
Review top news and interview highlights from the week ending January 19, 2024.
CGTLive’s Weekly Rewind – January 12, 2024
Review top news and interview highlights from the week ending January 12, 2024.
FDA Activity Recap: December 2023 Features 2 Major Approvals, Meetings, and Clinical Holds
CGTLive’s Weekly Rewind – January 5, 2024
Review top news and interview highlights from the week ending January 5, 2024.
CGTLive's Pillars of Progress 2023: Top FDA Approval News in Cell and Gene Therapy
Take a look at the stories that stood out as pillars of progress and success in endocrinology gene and cell therapy development in 2023.
CGTLive's 2023 Pillars of Progress: Most-Watched Expert Interviews
This year we reached out to numerous experts outside the context of the conference cycle to seek their insight on company announcements, pipeline therapies, and disease awareness days.
CGTLive's Pillars of Progress 2023: Most-Read Features
Take a look at our most-read features from 2023 that explored the biggest current topics and concerns with gene and cell therapy development across treatment fields.
CGTLive's 2023 Pillars of Progress: Most-Read Conference Coverage Stories
Take a look at the stories that stood out as pillars of progress and success from all of CGTLive's coverage of major 2023 medical society meetings and conferences.